Jason Adair
Corporate Officer/Principal bei Liquidia Technologies, Inc.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Jason Adair's current job is Vice President-Corporate Development & Strategy at Liquidia Technologies, Inc. He started this position in 2016.
Mr. Adair's former job was Executive Director-Corporate Development at BioCryst Pharmaceuticals, Inc. He held this position from 2011 to 2015.
He also worked as Vice President-Corporate Development & Strategy at Liquidia Corp.Mr. Adair's education includes an undergraduate degree from Wake Forest University and an MBA from Tuck School of Business at Dartmouth.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION
0,15% | 12.04.2024 | 111 537 ( 0,15% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Jason Adair
| Unternehmen | Position | Beginn |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 14.01.2016 |
Ehemalige bekannte Positionen von Jason Adair
| Unternehmen | Position | Ende |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2015 |
| LIQUIDIA CORPORATION | Investor Relations Contact | - |
Ausbildung von Jason Adair
| Wake Forest University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
